Acknowledgements We thank Ruth B Murray for reviewing and editing this manuscript. We thank Joan B Soriano for his critical review and constructive comments. We thank Helga Mikkelsen and Alessandra Cifra for their assistance with manuscript editing and revision. Finally, we thank the Journal blind peer reviewers, whose suggestions and critical appraisal significantly improved our original submission. FUNDING This study was funded by Meda, Solna, Sweden. Data acquisition and analyses were funded by Meda. The study was conducted by Research in Real Life as an independent research organisation; Meda had no role in the conduct or reporting of the study.Peer reviewedPublisher PD
Background: Allergic rhinitis is a common disease altering quality of life. Its treatment is well es...
Allergic rhinitis (AR) is very commonly caused by pollens. The symptoms of AR consist of sneezing, n...
<b>Background</b> Despite the availability of evidence-based guidelines for managing all...
Little data on UK prescribing patterns and treatment effectiveness for allergic rhinitis (AR) are av...
Little data on UK prescribing patterns and treatment effectiveness for allergic rhinitis (AR) are av...
Funding Funding for this survey was provided by Meda Pharma.Peer reviewedPublisher PD
Funding This work was supported by MEDA Pharma GmbH & Co KG.Peer reviewedPublisher PD
Background: Allergic rhinitis (AR) has high prevalence and substantial socio-economic burden. Mater...
Pharmacists have a valuable role in the management of allergic rhinitis (AR) at the community pharma...
Background: Allergic rhinitis (AR) represents a major challenge in primary care. The Allergic Rhinit...
Allergic rhinitis (AR) is a frequent presenting problem in primary care in the UK, and has increased...
Background and objective: the global prevalence of allergic rhinitis (AR) is rising and yet there is...
<p><b>Objective:</b> To investigate recent trends in the recorded incidence, lifet...
Objective To investigate recent trends in the recorded incidence, lifetime prevalence and prescribin...
Background: Allergic Rhinitis (AR) is a high-prevalence disease. In Europe about 25% of the general ...
Background: Allergic rhinitis is a common disease altering quality of life. Its treatment is well es...
Allergic rhinitis (AR) is very commonly caused by pollens. The symptoms of AR consist of sneezing, n...
<b>Background</b> Despite the availability of evidence-based guidelines for managing all...
Little data on UK prescribing patterns and treatment effectiveness for allergic rhinitis (AR) are av...
Little data on UK prescribing patterns and treatment effectiveness for allergic rhinitis (AR) are av...
Funding Funding for this survey was provided by Meda Pharma.Peer reviewedPublisher PD
Funding This work was supported by MEDA Pharma GmbH & Co KG.Peer reviewedPublisher PD
Background: Allergic rhinitis (AR) has high prevalence and substantial socio-economic burden. Mater...
Pharmacists have a valuable role in the management of allergic rhinitis (AR) at the community pharma...
Background: Allergic rhinitis (AR) represents a major challenge in primary care. The Allergic Rhinit...
Allergic rhinitis (AR) is a frequent presenting problem in primary care in the UK, and has increased...
Background and objective: the global prevalence of allergic rhinitis (AR) is rising and yet there is...
<p><b>Objective:</b> To investigate recent trends in the recorded incidence, lifet...
Objective To investigate recent trends in the recorded incidence, lifetime prevalence and prescribin...
Background: Allergic Rhinitis (AR) is a high-prevalence disease. In Europe about 25% of the general ...
Background: Allergic rhinitis is a common disease altering quality of life. Its treatment is well es...
Allergic rhinitis (AR) is very commonly caused by pollens. The symptoms of AR consist of sneezing, n...
<b>Background</b> Despite the availability of evidence-based guidelines for managing all...